Results 21 to 30 of about 4,368,112 (356)

Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results

open access: yesInternational Journal of Endocrinology, 2012
Background. Primary hyperparathyroidism (PHPT) is associated with high cardiovascular morbidity, and the role of calcium and parathyroid hormone is still controversial. Objective.
Petramala Luigi   +12 more
doaj   +1 more source

Secondary hypertension

open access: yesSouth African Family Practice, 2011
Secondary hypertension is rare and the diagnosis may be challenging although, on occasion, there are clinical features indicative of a specific underlying cause.
J.A. Ker
doaj   +1 more source

Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)

open access: yesЕвразийский Кардиологический Журнал, 2023
Disclaimer. The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.
I. E. Chazova   +16 more
doaj   +1 more source

Bone and Mineral Metabolism in Patients with Primary Aldosteronism

open access: yesInternational Journal of Endocrinology, 2014
Primary aldosteronism represents major cause of secondary hypertension, strongly associated with high cardiovascular morbidity and mortality. Aldosterone excess may influence mineral homeostasis, through higher urinary calcium excretion inducing ...
Luigi Petramala   +9 more
doaj   +1 more source

SECONDARY (ENDOCRINE) HYPERTENSION: LECTURE

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Hypertension is a  very common disease with high morbidity and reduction in quality of life. Endocrine disorders are the most common cause of secondary hypertension affecting ~3% of the population.
M. Yu. Yukina   +3 more
doaj   +1 more source

Pheochromocytoma-induced hypertensive retinopathy

open access: yesTNOA Journal of Ophthalmic Science and Research, 2022
Pheochromocytoma is an important cause of secondary hypertension that can lead to hypertensive retinopathy. In such cases, changes are often reversible and the condition remains stable once the required treatment is done at an early stage.
Suklengmung Buragohain   +4 more
doaj   +1 more source

Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. [PDF]

open access: yes, 2016
ObjectiveTo compare different blood pressure (BP) levels in their association with the risk of renal outcomes in type 1 diabetes and to determine whether an intensive glycemic control strategy modifies this association.Research design and methodsWe ...
Gitelman, Stephen E   +5 more
core   +2 more sources

Pheochromocytoma: A Rare Cause of Secondary Hypertension

open access: yesJournal of Lumbini Medical College, 2013
Introduction: Pheochromocytoma is a rare tumor, originating from the chromaffin tissue. Its frequency is approximately 1/100,000. The clinical manifestation is due to catecholamine excess, which includes high blood pressure, palpitation, headache ...
Sahadeb Prasad Dhungana   +3 more
doaj   +1 more source

Apparent mineralocorticoid excess - A rare cause of endocrine hypertension

open access: yesIndian Pediatrics Case Reports, 2022
Background: Endocrine causes of hypertension constitute a very small percentage of patients with secondary hypertension. Apparent mineralocorticoid excess (AME) is a rare genetic form of young-onset secondary hypertension.
Sonali Verma   +2 more
doaj   +1 more source

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. [PDF]

open access: yes, 2013
BACKGROUND: Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension. METHODS: In this phase 3,
CHEST-1 Study Group,   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy